Opinion on — the Commission communication on the extension of the pharmaceutical Directives to medicinal products not yet covered, — the proposal for a Council Directive amending Directives 65/65/EEC, 75/ 318/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products, — the proposal for a Council Directive extending the scope of Directives 65/ 65/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products and laying down additional provisions for immunological medicinal products consisting of vaccines, toxins or serums and allergens, — the proposal for a Council Directive extending the scope of Directives 65/ 65/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products and laying down additional provisions for medicinal products derived from human blood, and — the proposal for a Council Directive extending the scope of Directives 65/ 65/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products and laying down additional provisions for radiopharmaceuticals